Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...

A small number of patients using GLP-1 weight loss medications have experienced vision loss, although researchers have not ...

Boone Health is closing its bariatric clinic in Columbia because of lagging demand. "We're working to expand the high-demand ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.

WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...

Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems ... and tirzepatide (brand names Mounjaro and Zepbound). The paper is one of ...

Similarly, Zepbound is Mounjaro’s weight-loss counterpart ... said many of his patients report life-changing weight loss while on GLP-1 medications. “I have some veterans who have lost ...